Baxter Adds Recombinant Protein to Specialty Therapeutics... (ding. Platelet adherence ismediated by n...)

Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio

Date:10/16/2007

ding. Platelet adherence is mediated by naturally occurring von Willebrand factor (VWF), a large protein found in the circulating blood, and naturally occurring ADAMTS13, an enzyme that plays a critical role in hemostasis by actively regulating the function of VWF.

Under the terms of this agreement, Kaketsuken will provide Baxter with access to Kaketsuken's intellectual property rights concerning the recombinant protein. Baxter has an exclusive license to the recombinant ADAMTS13 intellectual property rights worldwide, except for Japan where Baxter has a co-exclusive license to commercialize recombinant ADAMTS13 with Kaketsuken. In addition to an upfront payment upon signing the agreement, Baxter will pay Kaketsuken milestone payments upon Investigational New Drug (IND) filing, initiation of Phase II and Phase III trials, Biologics License Application (BLA) filings and US Food and Drug Administration approval of recombinant ADAMTS13.

The inclusion of ADAMTS13 in Baxter's pre-clinical portfolio fits into the company's platform of specialty pharmaceuticals. Baxter has pioneered protein therapies developed from the separation and purification of important blood components and recombinant technologies, applying its knowledge and resources to become a leader in blood-related disorders such as hemophilia and other immune deficiencies. Baxter is recognized as a global leader in hemophilia therapies with a growing portfolio of innovative therapies and technologies, developed through strategic collaborations and internal research and development.

About TTP

TTP is a thrombotic disorder that is caused by the formation of platelet- rich thrombi in blood vessels throughout the body. Hereditary TTP, also known as Upshaw Schulman syndrome, is caused by detrimental mutations of the ADAMTS13 gene, resulting in severe ADAMTS13 deficiency, whereas acquired TTP is often due to auto-antibodies directed against ADAMTS13. Characterized by bruising, anemia, fever, n
'/>"/>

2

GOOD

Page: 1 2 3 4
Related biology technology :

1. Expression and Purification of Recombinant Proteins That Have Native Amino Acid Sequence
2. Proteinase K, Recombinant, PCR Grade: the Ideal Tool for Template Preparations
3. Recombinant HIV Reverse Transcriptase
4. Purification of Recombinant Flavonone 3beta-Hydroxylase Using Bio-Scale CHT5-1 Hydroxyapatite Column
5. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
6. Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening
7. Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
8. A New C-Terminal GST Vector for Protein Production in S. pombe
9. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
10. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
11. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins

Post Your Comments:

Baxter Adds Recombinant Protein to Specialty Therapeutics...(ding. Platelet adherence ismediated by n...)